Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention

American Journal of Lifestyle Medicine

Volumn 4, Issue 1, 2010, Pages 32-37

  Dasgupta, Nabarun ^a   Sanford, Catherine ^a   Albert, Susan ^a   Wells Brason, Fred ^a  

^a Project Lazarus   (United States)

Author keywords

drug overdose; naloxone; opioid; prescription drugs; Project Lazarus

Indexed keywords

EID: 84990385501     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827609348462     Document Type: Review

References (55)

1. Fingerhut LA Increases in Poisoning and Methadone-Related Deaths: United States, 1999-2005. NCHS Health E-Stats, February 2008. at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/poisoning/poisoning.pdf. Accessed July 31, 2009.
2. Fingerhut LA, Anderson RN The Three Leading Causes of Injury Mortality in the United States, 1999-2005. NCHS Health E-Stats. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/injury99-05/injury99-05.pdf. Accessed July 10, 2009.
3. Paulozzi L., Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006; 15: 618-627.
4. Centers for Disease Control and Prevention. QuickStats: motor-vehicle traffic and poisoning death rates, by age-United States, 2005-2006. MMWR Morb Mortal Wkly Rep. 2009; 58: 753.
5. Belluck P. Methadone, once the way out, suddenly grows as a killer drug. New York Times. February 9, 2003.
6. Meier B. In guilty plea, OxyContin maker to pay $600 million. New York Times. May 10, 2007.
7. Lewis J. Searches in inquiry into death of model. New York Times. October 13, 2007.
8. Cave D. Legal drugs kill far more than illegal, Florida says. New York Times. June 14, 2008.
9. Tuhus M. Hope seen in drug overdose. New Haven Independent. March 27, 2009.
10. Posner G. Chopra: Michael Jackson could have been saved. General Posner the Daily Beast. July 2, 2009.
11. Centers for Disease Control and Prevention. QuickStats: age-adjusted death rates per 100,000 population for the three leading causes of injury death, United States, 1979-2006. MMWR Morb Mortal Wkly Rep. 2009; 58: 675.
12. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS). www.cdc.gov/ncipc/wisqars. Accessed July 10, 2009.
13. North Carolina State Center for Health Statistics. Deaths and Mortality Rates From Unintentional Poisonings and Poisonings of Undetermined Intent by Decedent-s County of Residents: North Carolina Residents, 2006 and 2007 Combined. Raleigh: North Carolina State Center for Health Statistics; 2008.
14. Paulozzi L. The Epidemiology of Fatal Drug Overdoses: Potential for Prevention. 2008. http://www.stipda.org/displaycommon.cfm?an=1&subarticlenbr=203. Accessed July 16, 2009.
15. Shah NG, Lathrop SL, Reichard RR, Landen MG Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction. 2008; 103: 126-136.
16. Dasgupta N., Jöhsson Funk M., Brownstein JS Comparing unintentional opioid poisoning mortality in metropolitan and non-metropolitan counties, United States, 1999-2003. In: Thomas Y, Richardson D, Cheung I, eds. Geography and Drug Addiction. New York: Springer; 2008: 175-192.
17. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300: 2613-2620.
18. Wunsch MJ, Nakamoto K., Behonick G., Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009; 18: 5-14.
19. Dasgupta N., Kramer A., Zalman MA, et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend. 2006; 82: 135-142.
20. US Department of Justice, National Drug Intelligence Center. Methadone Diversion, Misuse and Abuse: Deaths Increasing at an Alarming Rate. http://www.usdoj.gov/ndic/pubs25/25930/index.htm. Accessed July 31, 2009.
21. Zinberg NE Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. New Haven, CT: Yale University Press; 1984.
22. Budnitz DS, Layde PM Outpatient drug safety: new steps in an old direction. Pharmacoepidemiol Drug Saf. 2007; 16: 160-165.
23. Dasgupta N. Community-Oriented Interventions and Roles of the Pharmaceutical Industry. http://radars.org/Portals/1/RADARS(R)%20System_2009%20Annual%20Meeting%20Summary_Website.pdf. Accessed July 15, 2009.
24. State and Territorial Injury Prevention Directors Association (STIPDA). State Strategies for Preventing Prescription Drug Overdoses. http://www.stipda.org/displaycommon.cfm?an=1&subarticlenbr=202. Accessed July 15, 2009.
25. Center for Lawful Access and Abuse Deterrence. National Prescription Drug Abuse Prevention Strategy, 2009. http://www.claad.org/downloads/Nat_Prescipt_Drug_Abuse_Prev_Strat_2009.pdf. Accessed July 15, 2009.
26. National Drug Intelligence Center, US Department of Justice. National Prescription Drug Threat Assessment, 2009. http://www.usdoj.gov/ndic/pubs33/33775/index.htm. Accessed July 15, 2009.
27. Carrieri MP, Amass L., Lucas GM, Vlahov D., Wodak A., Woody GE Buprenorphine use: the international experience. Clin Infect Dis. 2006; 43: S197-S215.
28. Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008; 94: 151-157.
29. Emmanuelli J., Desenclos JC Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction. 2005; 100: 1690-1700.
30. Johnson E. Utah Clinical Guidelines on Prescribing Opioids: Utah Clinical Guidelines on Prescribing Opioids. http://www.stipda.org/displaycommon.cfm?an=1&subarticlenbr=202andwww.useonlyasdirected.org. Accessed July 15, 2009.
31. Neven D. The Consistent Care Program. http://www.stipda.org/displaycommon.cfm?an=1&subarticlenbr=202. Accessed July 15, 2009.
32. Sanford C, ed. Findings and Recommendations of the Task Force to Prevent Deaths From Unintentional Drug Overdoses in North Carolina, 2003. http://www.injuryfreenc.ncdhhs.gov/About/TaskForcetoPreventDrugDeaths.pdf. Accessed July 31, 2009.
33. Sporer KA Strategies for preventing heroin overdose. BMJ. 2003; 326: 442-444.
34. Seal KH, Downing M., Kral AH, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health. 2003; 80: 291-301.
35. Zador D., Sunjic S., Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996; 164: 204-207.
36. Davidson PJ, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health. 2003; 80: 261-273.
37. Davidson PJ, Ochoa KC, Hahn JA, Evans JL, Moss AR Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction. 2002; 97: 1511-1516.
38. Latkin CA, Hua W., Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend. 2004; 73: 61-67.
39. Seal KH, Thawley R., Gee L., et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005; 82: 303-311.
40. Sporer KA, Kral AH Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med. 2007; 49(2): 172-177.
41. Best D., Gossop M., Man LH, Stillwell G., Coomber R., Strang J. Peer overdose resuscitation: multiple intervention strategies and time to response by drug users who witness overdose. Drug Alcohol Rev. 2002; 21: 269-274.
42. Darke S., Hall W. The distribution of naloxone to heroin users. Addiction. 1997; 92: 1195-1199.
43. Dettmer K., Saunders B., Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001; 322: 895-896.
44. Galea S., Worthington N., Piper TM, Nandi VV, Curtis M., Rosenthal DM Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006; 31: 907-912.
45. Graham CA, McNaughton GW, Ireland AJ, Cassells K. Take home naloxone for opiate addicts: drug misusers may benefit from training in cardiopulmonary resuscitation. BMJ. 2001;323: 934.
46. Green TC, Heimer R., Grau LE Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008; 103: 979-989.
47. Maxwell S., Bigg D., Stanczykiewicz K., Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25: 89-96.
48. Piper TM, Stancliff S., Rudenstine S., et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse. 2008; 43: 858-870.
49. Strang J., Kelleher M., Best D., Mayet S., Manning V. Emergency naloxone for heroin overdose. BMJ. 2006; 333: 614-615.
50. Strang J., Manning V., Mayet S., et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008; 103: 1648-1659.
51. Burris S. Legality of Prescribing Take-Home Naloxone to Treat Opioid Overdose in North Carolina: A Memorandum. 2007. http://www.temple.edu/lawschool/aidspolicy/default.htm. Accessed July 31, 2009.
52. Kim D., Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009; 99: 402-407.
53. Doe-Simkins M., Walley AY, Epstein A., Moyer P. Saved by the nose: bystanderadministered intranasal hydrochloride for opioid overdose. Am J Public Health. 2009; 99: 788-791.
54. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project, State Inpatient Databases, 2005. http://www.hcup-us.ahrq.gov/db/nation/nis/reports/NIS_2005_Design_Report.pdf. Accessed January 28, 2008.
55. Corso P., Finkelstein E., Miller T., Fiebelkorn I., Zaloshnja E. Incidence and lifetime costs of injuries in the United States. Inj Prev. 2006; 12: 212-218.